Glucocorticoid receptor polymorphisms and bone mineral density in patients receiving conventional glucocorticoid replacement
our study did not confirm a significant association of NR3C1 polymorphisms with BMD in AD patients receiving long-term GC replacement. Currently recommended GC substitution doses seem less harmful to bone, but prospective analyses in larger cohorts of patients are warranted.
Authors
- Marta Fichna (ORCID: https://orcid.org/0000-0003-2865-7074)
- Marek A. Ruchała (ORCID: https://orcid.org/0000-0001-9743-2405)
- Magdalena Żurawek (ORCID: https://orcid.org/0000-0002-0345-4054)
- Elżbieta Wrotkowska (ORCID: https://orcid.org/0000-0003-0965-7300)
- Katarzyna Furman
Institutions
- Poznan University of Medical Sciences (PL)
- Institute of Human Genetics (PL)
- Polyclinic General Hospital (GR)
- Polish Academy of Sciences (PL)
Publication Details
- Journal
- Endokrynologia Polska
- Published
- 2025-09-25
- DOI
- https://doi.org/10.5603/ep.106658
- Primary Topic
- Adrenal Hormones and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00